Privi Speciality Chemicals Earnings Call Transcript: Key Takeaways
Record Q2 revenue ₹773 Cr (+13.9%), EBITDA ₹212 Cr (+16.7%), PAT ₹117 Cr (+24.6%). H1 growth is about 15%, yet management reiterates 20% for FY27, which needs a sharp H2 acceleration.
- Call
- Guides 20% growth